Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Arcadia Biosciences, Inc. (RKDA) had Normalized Pre-Tax Income of $-6.27M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$1.44M |
|
$-6.27M |
|
$0.81M |
|
$0.63M |
|
$1.94M |
|
$-0.50M |
|
$-5.77M |
|
$-6.27M |
|
|
Normalized Pre-Tax Income |
$-6.27M |
$-6.27M |
|
$-6.27M |
|
$-6.27M |
|
$-6.27M |
|
$-0.50M |
|
$-0.50M |
|
2.99M |
|
2.99M |
|
$-2.09 |
|
$-2.09 |
|
| Balance Sheet Financials | |
$5.74M |
|
-- |
|
$0.15M |
|
$5.89M |
|
$1.65M |
|
-- |
|
$3.61M |
|
$5.26M |
|
$0.63M |
|
$0.59M |
|
$0.63M |
|
2.18M |
|
| Cash Flow Statement Financials | |
$-1.42M |
|
-- |
|
$5.34M |
|
$0.26M |
|
$4.18M |
|
$3.92M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
43.73% |
|
-34.37% |
|
-34.37% |
|
-- |
|
-434.23% |
|
-434.23% |
|
$-1.42M |
|
-- |
|
-- |
|
-- |
|
0.24 |
|
0.87 |
|
2.58 |
|
34.86 |
|
-989.90% |
|
-1054.88% |
|
-106.33% |
|
-989.89% |
|
$0.29 |
|
$-0.47 |
|
$-0.47 |
|